tetano
Editor, Senior Moderator
Influenza Other Respir Viruses. 2019 Dec 13. doi: 10.1111/irv.12706. [Epub ahead of print] [h=1]Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines.[/h]
Krammer F[SUP]1[/SUP], Weir JP[SUP]2[/SUP], Engelhardt O[SUP]3[/SUP], Katz JM[SUP]4[/SUP], Cox RJ[SUP]5[/SUP].
[h=3]Author information[/h] 1 Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA. 2 Division of Viral Products, Food and Drug Administration, Bethesda, MD, USA. 3 Division of Virology, National Institute for Biological Standards and Control, Potters Bar, UK. 4 Formerly Influenza Branch, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. 5 Department of Clinical Science, Influenza Centre, University of Bergen, Bergen, Norway.
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] This report summarizes the discussions and conclusions from the "Immunological Assays and Correlates of Protection for Next-Generation Influenza Vaccines" meeting which took place in Siena, Italy, from March 31, 2019, to April 2, 2019.
[h=4]CONCLUSIONS:[/h] Furthermore, we review current correlates of protection against influenza virus infection and disease and their usefulness for the development of next generation broadly protective and universal influenza virus vaccines.
Published 2019. This article is a U.S. Government work and is in the public domain in the USA. Influenza and Other Respiratory Viruses published by John Wiley& Sons Ltd.
[h=4]KEYWORDS:[/h] CD4; CD8; HI; MN; NI; correlates of protection; influenza; influenza vaccine; mucosal immunity; stalk antibodies
PMID: 31837101 DOI: 10.1111/irv.12706
Free full text
Krammer F[SUP]1[/SUP], Weir JP[SUP]2[/SUP], Engelhardt O[SUP]3[/SUP], Katz JM[SUP]4[/SUP], Cox RJ[SUP]5[/SUP].
[h=3]Author information[/h] 1 Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA. 2 Division of Viral Products, Food and Drug Administration, Bethesda, MD, USA. 3 Division of Virology, National Institute for Biological Standards and Control, Potters Bar, UK. 4 Formerly Influenza Branch, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. 5 Department of Clinical Science, Influenza Centre, University of Bergen, Bergen, Norway.
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] This report summarizes the discussions and conclusions from the "Immunological Assays and Correlates of Protection for Next-Generation Influenza Vaccines" meeting which took place in Siena, Italy, from March 31, 2019, to April 2, 2019.
[h=4]CONCLUSIONS:[/h] Furthermore, we review current correlates of protection against influenza virus infection and disease and their usefulness for the development of next generation broadly protective and universal influenza virus vaccines.
Published 2019. This article is a U.S. Government work and is in the public domain in the USA. Influenza and Other Respiratory Viruses published by John Wiley& Sons Ltd.
[h=4]KEYWORDS:[/h] CD4; CD8; HI; MN; NI; correlates of protection; influenza; influenza vaccine; mucosal immunity; stalk antibodies
PMID: 31837101 DOI: 10.1111/irv.12706
Free full text